- Trials with a EudraCT protocol (21)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (38)

These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006). | |
Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records. |
Study title: Pharmacokinetics of teicoplanin in children. - Tarral E, Jehl F, Tarral A et al. (1988) - Journal of Antimicrobial Chematherapy 21, Supplement A, 47-51. |
Active substance: TEICOPLANIN |
Study summary document link (including results): |
View full study record |
Document reference: 44306 |
Study title: Report in Clinical documentation for Marketing Authorisation Application (June 1987): Clinical study of the efficacy and safety of teicoplanin in the treatment of Gram-positive infections - Schiraldi O., Terragna A., De Rosa F., Olivero S. - 4 March 1987Report in Clinical documentation for Marketing Authorisation Application (June 1987): Clinical study of the efficacy and safety of teicoplanin in the treatment of Gram-positive infections - Schiraldi O., Terragna A., De Rosa F., Olivero S. - 4 March 1987 |
Active substance: TEICOPLANIN |
Study summary document link (including results): |
View full study record |
Document reference: 44316 |
Study title: Report in Clinical documentation for Marketing Authorisation Application (June 1987): Drug experience reports on 2 children receiving overdosage of teicoplaninReport in Clinical documentation for Marketing Authorisation Application (June 1987): Drug experience reports on 2 children receiving overdosage of teicoplanin |
Active substance: TEICOPLANIN |
Study summary document link (including results): |
View full study record |
Document reference: 44317 |
Study title: Report in Clinical documentation for Marketing Authorisation Application (June 1987): Efficacy and tolerability of teicoplanin in infections caused by Gram-positive organisms - Del Favero A. - 28 November 1985Report in Clinical documentation for Marketing Authorisation Application (June 1987): Efficacy and tolerability of teicoplanin in infections caused by Gram-positive organisms - Del Favero A. - 28 November 1985 |
Active substance: TEICOPLANIN |
Study summary document link (including results): Teicoplanin STUDY Gram positive - Del Favero.xls |
View full study record |
Document reference: 44318 |
Study title: Report in Clinical documentation for Marketing Authorisation Application (June 1987): Evaluation of therapeutic efficacy and tolerability of teicoplanin in serious infections caused by Gram-positive micro-organisms - Martino - 28 November 1985Report in Clinical documentation for Marketing Authorisation Application (June 1987): Evaluation of therapeutic efficacy and tolerability of teicoplanin in serious infections caused by Gram-positive micro-organisms - Martino - 28 November 1985 |
Active substance: TEICOPLANIN |
Study summary document link (including results): Teicoplanin STUDY Serious infections - Martino.xls |
View full study record |
Document reference: 44320 |
Study title: Report in Clinical documentation for Marketing Authorisation Application (March 1987): European Multicentre open study of teicoplanin in Gram-positive infection ; 1987 sponsor summary - P.J. Lewis - 6 April 1987 |
Active substance: TEICOPLANIN |
Study summary document link (including results): Teicoplanin STUDY EG-87-42.xls |
View full study record |
Document reference: 44310 |
Study title: Report in Clinical documentation for Marketing Autorisation Application (June 1987): Clinical Pharmacology of teicoplanin in children - Milner R.D.G., Whincup G. - 1985Report in Clinical documentation for Marketing Autorisation Application (June 1987): Clinical Pharmacology of teicoplanin in children - Milner R.D.G., Whincup G. - 1985 |
Active substance: TEICOPLANIN |
Study summary document link (including results): Teicoplanin STUDY pharmacological.xls |
View full study record |
Document reference: 44315 |
Study title: Report in Clinical documentation for Marketing Autorisation Application (June 1987): Clinical study of the efficacy and safety of teicoplanin in the treatment of Gram-positive infections - Concia E., Andreoni M., Suter F. - 4 March 1987 |
Active substance: TEICOPLANIN |
Study summary document link (including results): Teicoplanin STUDY DRC 357.DLI.1075.xls |
View full study record |
Document reference: 44296 |
Study title: Report in Clinical documentation for Marketing Autorisation Application (June 1987): Clinical study of the efficacy and safety of teicoplanin in the treatment of Gram-positive infections - Dietrich H.A., Fell J.J., Pugnetti P. - 6 February 1987 |
Active substance: TEICOPLANIN |
Study summary document link (including results): Teicoplanin STUDY LP-SM-0025.xls |
View full study record |
Document reference: 44297 |
Study title: Report in Clinical documentation for Marketing Autorisation Application (June 1987): Clinical study of the efficacy and safety of teicoplanin in the treatment of Gram-positive infections - Schiraldi O., Terragna A., De Rosa F., Olivero S. - 4 March 1987 |
Active substance: TEICOPLANIN |
Study summary document link (including results): Teicoplanin STUDY DRC 356.DLI.1074.xls |
View full study record |
Document reference: 44298 |
Study title: Report in Clinical documentation for Marketing Autorisation Application (June 1987): Efficacy and safety of teicoplanin in the treatment of infections caused by Gram-positive cocci. A summary report of over 298 cases treated in France - Garaud J.J., Tarra -17/02/1987 |
Active substance: TEICOPLANIN |
Study summary document link (including results): Teicoplanin STUDY EG-87.03.xls |
View full study record |
Document reference: 44299 |
Study title: Report in Clinical documentation for Marketing Autorisation Application (June 1987): Efficacy and tolerability of teicoplanin in infections caused by Gram-positive organisms - Martinetto P. - 22 November 1985Report in Clinical documentation for Marketing Autorisation Application (June 1987): Efficacy and tolerability of teicoplanin in infections caused by Gram-positive organisms - Martinetto P. - 22 November 1985 |
Active substance: TEICOPLANIN |
Study summary document link (including results): Teicoplanin STUDY Gram positive - Martinetto.xls |
View full study record |
Document reference: 44319 |
Study title: Report in Clinical documentation for Marketing Autorisation Application (June 1987): European Multicentre open study of teicoplanin in Gram-positive infection ; 1987 sponsor summary - P.J. Lewis - 6 April 1987 |
Active substance: TEICOPLANIN |
Study summary document link (including results): Teicoplanin STUDY EG-87-42.xls |
View full study record |
Document reference: 44300 |
Study title: Report in Clinical documentation for Marketing Autorisation Application (June 1987): Evaluation of therapeutic efficacy and tolerability of teicoplanin in serious infections caused by Gram-positive micro-organisms - Terragna A. - 28 November 1985Report in Clinical documentation for Marketing Autorisation Application (June 1987): Evaluation of therapeutic efficacy and tolerability of teicoplanin in serious infections caused by Gram-positive micro-organisms - Terragna A. - 28 November 1985 |
Active substance: TEICOPLANIN |
Study summary document link (including results): Teicoplanin STUDY Serious infections - Terragna.xls |
View full study record |
Document reference: 44321 |
Study title: Report in Clinical documentation for Marketing Autorisation Application (June 1987): Pharmacokinetics of teicoplanin in paediatric patients - Rosina R., Bernareggi A., Danese A., Cavenaghi L - 14 November 1986 |
Active substance: TEICOPLANIN |
Study summary document link (including results): Teicoplanin STUDY DRC 348.DLI 1039.xls |
View full study record |
Document reference: 44301 |
Study title: Report in Clinical documentation for Marketing Autorisation Application (June 1987): Teicoplanin in combination therapy for febrile episodes in neutropenic and non-neutropenic paediatric patients - Garaud J.J. - 9 March 1987 |
Active substance: TEICOPLANIN |
Study summary document link (including results): Teicoplanin STUDY EG-87-16.xls |
View full study record |
Document reference: 44302 |
Study title: Summary - Clinical documentation for Marketing Autorisation Application - June 1987Summary - Clinical documentation for Marketing Autorisation Application - June 1987 |
Active substance: TEICOPLANIN |
Study summary document link (including results): |
View full study record |
Document reference: 44322 |
Study title: Summary of clinical studies of the efficacy and safety of teicoplanin in the treatment of Gram-positive infections in the UK and Eire- Concia E., Andreoni M., Suter F. - 4 March 1987 ; Report in Clinical documentation for Marketing Autorisation Application - June 1987 |
Active substance: TEICOPLANIN |
Study summary document link (including results): |
View full study record |
Document reference: 44303 |
Study title: Teicoplanin in combination therapy for febrile episodes in neutropenic and non-neutropenic paediatric patients. - Lemerle S, De la Roque F, Lamy R, et al. - J Antimicrob Chemother 1988; 21, S.A.: 112-116.Teicoplanin in combination therapy for febrile episodes in neutropenic and non-neutropenic paediatric patients. - Lemerle S, De la Roque F, Lamy R, et al. - J Antimicrob Chemother 1988; 21, S.A.: 112-116. |
Active substance: TEICOPLANIN |
Study summary document link (including results): |
View full study record |
Document reference: 44324 |
Study title: Teicoplanin in gram-positive paediatric infections. (Abstract) In: Abstracts of the 8th mediterranean congress of chemotherapy. - Careddi P, Boccazzi A, Mosconi G. - Athens, 24-29 May 1992: 236.Teicoplanin in gram-positive paediatric infections. (Abstract) In: Abstracts of the 8th mediterranean congress of chemotherapy. - Careddi P, Boccazzi A, Mosconi G. - Athens, 24-29 May 1992: 236. |
Active substance: TEICOPLANIN |
Study summary document link (including results): |
View full study record |
Document reference: 44325 |